D
D. Dunbar Ivy
Researcher at University of Colorado Denver
Publications - 392
Citations - 16545
D. Dunbar Ivy is an academic researcher from University of Colorado Denver. The author has contributed to research in topics: Pulmonary hypertension & Vascular resistance. The author has an hindex of 62, co-authored 371 publications receiving 14345 citations. Previous affiliations of D. Dunbar Ivy include Anschutz Medical Campus & Food and Drug Administration.
Papers
More filters
Journal ArticleDOI
Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society
Steven H. Abman,Georg Hansmann,Stephen L. Archer,D. Dunbar Ivy,Ian Adatia,Wendy K. Chung,Brian D. Hanna,Erika B. Rosenzweig,J. Usha Raj,David N. Cornfield,Kurt R. Stenmark,Robin H. Steinhorn,Bernard Thébaud,Jeffrey R. Fineman,Titus Kuehne,Jeffrey A. Feinstein,Mark K. Friedberg,Michael G. Earing,Robyn J. Barst,Roberta L. Keller,John Kinsella,Mary P. Mullen,Robin R. Deterding,Thomas J. Kulik,George B. Mallory,Tilman Humpl,David L. Wessel +26 more
TL;DR: A panel of experienced clinicians and clinician-scientists was assembled to review the current literature and to make recommendations on the diagnosis, evaluation, and treatment of pediatric pulmonary hypertension.
Journal ArticleDOI
Hypoplastic Left Heart Syndrome : Current Considerations and Expectations
Jeffrey A. Feinstein,D. Woodrow Benson,Anne M. Dubin,Meryl S. Cohen,Dawn M. Maxey,William T. Mahle,Elfriede Pahl,Juan Villafane,Ami B. Bhatt,Lynn F. Peng,Beth Ann Johnson,Alison L. Marsden,Curt J. Daniels,Nancy Rudd,Christopher A. Caldarone,Kathleen A. Mussatto,David L.S. Morales,D. Dunbar Ivy,J. William Gaynor,James S. Tweddell,Barbara J. Deal,Anke K. Furck,Geoffrey L. Rosenthal,Richard G. Ohye,Nancy S. Ghanayem,John P. Cheatham,Wayne Tworetzky,Gerard R. Martin +27 more
TL;DR: The current state of the art in the understanding and treatment of HLHS during the stages of care is presented, including perioperative care, interstage monitoring, and management strategies, and issues surrounding the genetics, developmental outcomes, and quality of life are addressed.
Journal ArticleDOI
Pediatric Pulmonary Hypertension
D. Dunbar Ivy,Steven H. Abman,Robyn J. Barst,Rolf M. F. Berger,Damien Bonnet,Thomas R. Fleming,Sheila G. Haworth,J. Usha Raj,Erika B. Rosenzweig,Ingram Schulze Neick,Robin H. Steinhorn,Maurice Beghetti +11 more
TL;DR: The updated Nice classification for PH has been enhanced to include a greater depth of CHD and emphasizes persistent PH of the newborn and developmental lung diseases, such as bronchopulmonary dysplasia and congenital diaphragmatic hernia.
Journal ArticleDOI
Clinical features of paediatric pulmonary hypertension: a registry study
Rudolphus Berger,Maurice Beghetti,Tilman Humpl,Gary E. Raskob,D. Dunbar Ivy,Zhi-Cheng Jing,Damien Bonnet,Ingram Schulze-Neick,Robyn J. Barst +8 more
TL;DR: Although dyspnoea and fatigue were the most frequent symptoms, syncope occurred in 31% (57 of 182) of patients with IPAH or FPAH and in 18% (eight of 45) of those with repaired congenital heart disease; no children with unrepaired congenital systemic-to-pulmonary shunts had syncope.
Journal ArticleDOI
Paediatric pulmonary arterial hypertension : updates on definition, classification, diagnostics and management
Erika B. Rosenzweig,Steven H. Abman,Ian Adatia,Maurice Beghetti,Damien Bonnet,Sheila G. Haworth,D. Dunbar Ivy,Rolf M. F. Berger +7 more
TL;DR: Although a lack of clinical trial data for the use of PAH-targeted therapy persists, emerging data are improving the identification of appropriate targets for goal-oriented therapy in children, and will likely improve future clinical trial design to enhance outcomes in paediatric PAH.